2 000 new building blocks are synthesized monthly. Here is an important update to our MedChem Highlights from April 2026
Recent News
-
13 May 2026 Press Release
Leveraging Public Infrastructure for Private Innovation: Enamine and PAL Align
Collaboration leverages PAL’s public research facilities and Enamine’s compound libraries and fragment progression support to accelerate fragment-based lead discovery (FBLD).
-
20 April 2026 Press Release
Enamine Strengthens Its Sustainable Procurement Program in 2026
In 2026, Enamine’s Sustainable Procurement Program is reaching a new level of maturity and impact. Building on many years of close cooperation with suppliers – and reinforced by global best practices – the Company is further strengthening its approach to responsible and sustainable procurement across the entire supply chain.
-
07 April 2026 Press Release
Chemspace, Enamine, and Paul Scherrer Institute Launch a Joint Service for Fragment-Based Lead Discovery
Chemspace, a drug discovery engine providing machine learning-guided support for hit identification, hit to lead, and lead optimization using the largest purchasable collection of chemicals and biologics, Enamine, a leading provider of small molecules and drug discovery services, and the Paul Scherrer Institute (PSI), the largest research institute for natural and engineering sciences in Switzerland, have announced today a strategic collaboration aimed at creating an efficient platform for fragment-based drug discovery in the ultra-large chemical space.
Upcoming events
-
May 24-28,
2026Delegates
Request product information
Please leave your request for any product you wish. We will be happy to search it for you in our databases or offer its custom synthesis











